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Aims and method Rates of prescriptions of antidepressants and suicide are
inversely correlated at an epidemiological level. Less attention has been paid to
relationships between other drugs used in mental health and suicide rates. Here we
tested relationships between prescriptions of anxiolytics and antipsychotics and
suicide rates in Scotland.
Results Suicide rates were inversely correlated with prescriptions of
antidepressants and antipsychotics over 14 years (2004–2018), and positively with
prescriptions of anxiolytics.
Clinical implications This illustrates the role of medications used in mental health
in suicide prevention, and highlights the importance of identifying causal mechanisms
that link anxiolytics with suicide.
Keywords Suicide; antidepressants; antipsychotics; anti-anxiety drugs;
epidemiology.
Increased prescriptions of antidepressants worldwide
have, at least at the population level, correlated with a
reduction in suicide rates.1 For example, negative relation-
ships have been reported between rates of prescription
of antidepressants and population suicide rates in adults
in the USA,2 Europe3 and Australia.4 This trend may,
however, be moderated by gender, as female suicide rates
were shown to be reduced with a corresponding increase
in antidepressant sales in Italy, whereas male rates
increased.5
Other classes of drug used in mental health, such as those
prescribed for psychotic illnesses (antipsychotics) or anxiety
(anxiolytics, hypnotics, benzodiazepines and barbiturates),
have received relatively less attention in relation to suicide
rates. Although there is evidence that elevated prescription
rates of antipsychotics for people with schizophrenia are
associated with a reduction in suicide rates in this patient
subgroup,6 effects on suicide rates more widely remain under-
explored. As antipsychotics are prescribed for conditions
other than psychosis (e.g. severe unipolar or bipolar depres-
sion), it is possible that antipsychotic prescription rates act
on population suicide rates in a similar way to antidepressants.
Furthermore, given a positive association between anxiety dis-
orders and suicidality,7 prescription of medications used to
treat anxiety may also reduce suicide rates.
Here we modelled relationships between prescriptions
of antipsychotics, anxiolytics and antidepressants and
monthly male and female suicide rates in Scotland from
2004 to 2018.
Method
We assert that all procedures contributing to this work com-
plied with the ethical standards of the relevant national and
institutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in 2008.
The research was approved by the University of Dundee
Research Ethics Committee.
Prescriptions of medications used in mental health
Dispensed quantities of medications from April 2004 to
December 2018 were provided by NHS Scotland’s
Information Services Division (NHS-ISD), for British
National Formulary (BNF) categories 4.1 Medications used
in anxiety (hypnotics, anxiolytics and benzodiazepines,
HAB), 4.2 Medications used in psychosis (antipsychotics)
and 4.3 Medications used in depression (antidepressants).
Dispensed quantities were operationalised as numbers of
paid items (i.e. number of items for which cost was reim-
bursed), as these best reflect the activity and costs associated
with prescribing and supply of medicines to patients in NHS
Scotland over time and is therefore the standard unit of
measurement of prescriptions used by NHS-ISD. These
data were freely available from NHS-ISD.
Suicide rates
Numbers of all probable male and female deaths by suicide
each month in Scotland from April 2004 to December 2018
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were obtained from the Scottish National Records Office. Data
represent date of death, rather than date of registration of
death. These were made available once a confidentiality state-
ment was signed. Cause of death was coded according to ICD
cause-of-death guidelines8 (i.e. deaths coded as ‘intentional
self-harm’ or ‘events of undetermined intent’). In 2011, the
way in which deaths from ‘acute intoxication’ were classified
changed. That is, some deaths that would previously have
been counted under ‘mental and behavioural disorders due to
psychoactive substance use’ were now counted under ‘poison-
ing’, which increased the number of deaths coded under ‘events
of undetermined intent’. Therefore, all analyses were con-
ducted using pre-2011 coding rules to ensure consistency in
the ways in which deaths were coded as suicide for the years
included in the study. Male and female monthly suicide rates
per 100 000 were computed based on the median annual popu-
lation estimate for 2004–2018 (n = 5.2 million; www.nomisweb.
co.uk).
Analyses
Moving averages over 3-month blocks were computed for
prescription and suicide rates in order to reduce the
impact of anomalous variation in rates across relatively
short time periods. We then fit bivariate linear regression
models separately for men and women to test the hypoth-
eses that rates of prescription of HAB, antipsychotics and
antidepressants predict male and female suicide rates. All
analyses were conducted with IBM SPSS Version 22 for
Windows.
Results
For descriptive statistics see Table 1.
Prescriptions of all three categories of medication
significantly predicted male and female suicide rates
(Table 1). Prescriptions of antipsychotics were related to
reduced suicide rates in men (β =−0.44, P < 0.001) and
women (β =−0.27, P < 0.001), as were prescriptions of anti-
depressants (men: β =−0.49, P < 0.001; women: β =−0.28,
P < 0.001). Prescriptions of HAB, however, were associated
with increased suicide rates in men (β = 0.41, P < 0.001)
and women (β = 0.24, P < 0.005).
Discussion
Rates of prescription of antidepressants and antipsychotics
predicted lower male and female suicide rates over
14 years in Scotland. Rates of prescription of HAB, however,
predicted higher male and female suicide rates.
Our results are consistent with previous research
which has shown that population-level prescription rates
of antidepressants are associated with reductions in sui-
cide rates.1–4 Unlike Barbui et al,5 however, we found
this to be the case for both men and women. The role of
antidepressants in suicide prevention must be considered
alongside evidence that suggests a potential risk of
increased suicidal behaviour following commencement
on antidepressants, particularly among children and ado-
lescents.9 Our data were for all probable suicides and
were not classified by age, so it is not possible to deter-
mine whether separate patterns exist across adults and
children and adolescents.
We found prescription rates of antipsychotics to be
related to reduced suicide rates for both men and women.
This is, to our knowledge, among the first evidence to sug-
gest that prescription of antipsychotics reduces population-
level suicide rates, extending the relationship beyond suicide
rates among people with schizophrenia.6 Given the use of
antidepressants and antipsychotics in depression, it is per-
haps not surprising that both are shown to reduce suicide
rates in our sample.
Prescriptions of HAB were found to be positively related
to suicide rates. That is, months with higher rates of pre-
scription of HAB also had higher rates of male and female
deaths by suicide. This is perhaps surprising given the asso-
ciation between anxiety disorders and suicidality.7 One pos-
sibility is that HAB are prescribed for a variety of difficulties,
including the spectrum of anxiety disorders and insomnia,
which may be chronic (e.g. as in generalised anxiety disorder
or obsessive–compulsive disorder) or acute (e.g. insomnia
linked to grief or a recent traumatic experience). This
means that prescriptions of HAB may be more closely linked
to incidence of acute distress (e.g. grief) and associated anx-
iety in the population than prescriptions of antipsychotics or
antidepressants.7,10 Alternatively, hypnotics have been
shown to correlate with increased risk for suicide by increas-
ing suicidal ideation.10
Table 1 Bivariate linear regression statistics for relationships between male and female suicide rates and numbers of paid items
of medications used in anxiety, psychosis and depression over 3-month moving averages
HAB prescriptions Antipsychotic prescriptions Antidepressant prescriptions
Prescription rate, mean (s.d.) 172 741.24 (4698.79) 67 314.2 (10 920.32) 40 9770.32, (45 782.31)
Female suicide rate (per 100 000):
mean = 0.32, s.d. = 0.05
Adj. R2 = 0.05 Adj. R2 = 0.07 Adj. R2 = 0.07
F1,174 = 10.65 F1,174 = 13.08 F1,174 = 14.65
β = 0.24* β =−0.27** β =−0.28**
Male suicide rate (per 100 000):
mean = 0.88, s.d. = 0.11
Adj. R2 = 0.16 Adj. R2 = 0.19 Adj. R2 = 0.24
F1,174 = 35.25 F1,174 = 41.65 F1,174 = 54.74
β = 0.41** β =−0.44** β =−0.49**
HAB, hypnotics, anxiolytics and benzodiazepines, prescribed for anxiety; adj., adjusted.
*P < 0.005, **P < 0.001.
2
ORIGINAL PAPER
Moore et al Psychotropic drug prescription and suicide rates
Downloaded from https://www.cambridge.org/core. 12 Oct 2021 at 16:13:14, subject to the Cambridge Core terms of use.
Our results are consistent with those of Lodhi & Shah,11
who demonstrated that the association between suicide and
prescription rates in an elderly population was negative for
prescriptions of selective serotonin reuptake inhibitor anti-
depressants, antimanics, antipsychotics and analgesics, and
positive for monoamine oxidase inhibitor antidepressants
and hypnotics, anxiolytics and barbiturates. Taken with
our findings in the general Scottish population, then, there
is growing evidence that HAB are associated with increased
suicide rates.
Our study was conducted across a relatively small geo-
graphical area and across a relatively brief period of time.
Therefore we cannot be certain that results will translate
to larger areas or longer periods. Our study cannot tell us
anything about the likelihood of an individual man or
woman dying by suicide as a result of their use of medica-
tions. We also cannot conclude, or infer without speculation,
causal mechanisms from our correlational results and it is
possible that unmeasured variables account for the relation-
ships we have demonstrated.
Given our finding that rates of male and female deaths by
suicide are positively related to prescriptions of HAB, we argue
that future work should seek to identify the extent to which
this relationship replicates across populations, as well as
mechanisms by which HAB may contribute to suicidality.
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